XML 15 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 27, 2021
Mar. 28, 2020
Mar. 27, 2021
Mar. 28, 2020
Net revenue $ 616,554 $ 722,751 $ 783,479 $ 1,388,676
Cost of revenue 352,892 413,958 396,519 771,032
Gross profit 263,662 308,793 386,960 617,644
Operating expenses:        
Selling, general and administrative 396,468 513,221 941,689 1,096,569
Product development 194,333 156,991 586,760 362,385
Total operating expenses 590,801 670,212 1,528,449 1,458,954
Operating loss (327,139) (361,419) (1,141,489) (841,310)
Other income (expense):        
Interest income 153 372
Interest expense (1,541) (3,702) (802)
Total other income (expense) (1,541) 153 470,698 (430)
Net loss $ (328,680) $ (361,266) (670,791) (841,740)
Grant income     $ 474,400
Net loss per common share:        
Basic (in dollars per share) $ (0.18) $ (0.20) $ (0.36) $ (0.46)
Diluted (in dollars per share) $ (0.18) $ (0.20) $ (0.36) $ (0.46)
Weighted average shares:        
Basic (in shares) 1,850,403 1,850,403 1,850,403 1,850,403
Diluted (in shares) 1,850,403 1,850,403 1,850,403 1,850,403
Net revenue $ 616,554 $ 722,751 $ 783,479 $ 1,388,676
Cost of revenue 352,892 413,958 396,519 771,032
Gross profit $ 263,662 $ 308,793 $ 386,960 $ 617,644